<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02714816</url>
  </required_header>
  <id_info>
    <org_study_id>MGT005</org_study_id>
    <nct_id>NCT02714816</nct_id>
  </id_info>
  <brief_title>Natural History Study of Patients With Leber Congenital Amaurosis Associated With Mutations in RPE65</brief_title>
  <official_title>Natural History Study of Patients With Leber Congenital Amaurosis Associated With Mutations in RPE65</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MeiraGTx UK II Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MeiraGTx UK II Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MGT005 is a natural history study to collect longitudinal prospective data from patients with
      Leber Congenital Amaurosis associated with defects in RPE65.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Leber Congenital Amaurosis (LCA) is a diagnosis for a group of severe, autosomal recessively
      inherited rod - cone dystrophies that typically result in complete visual loss in the third
      or fourth decade of life. One form, LCA2, is caused by a mutation in the gene encoding RPE56,
      an RPE-specific 65-kDa isomerase. Non-functional RPE65 results in photoreceptor cells that
      are unable to respond to light resulting in these patients being visually impaired.

      In preparation for human clinical trials, a detailed prospective phenotypic study will be
      undertaken to investigate the natural history of RPE65-LCA. Such a study will help identify
      suitable patients for therapeutic intervention. Furthermore through greater phenotyping an
      optimal window for intervention and specific parameters to help quantify effect and identify
      clinical end points may have been ascertained .
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of retinal structure and function</measure>
    <time_frame>6 years</time_frame>
    <description>Retinal structure will be analysed using Adaptive optics and SD-OCT and Fundal autofluorescence. This will be correlated with assessment of visual acuity, psychophysical visual assessment, visual mobility, retinal sensitivity and visual fields</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Questionnaires</measure>
    <time_frame>6 years</time_frame>
    <description>Assessment of Visual impairment using appropriate, validated questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal Sensitivity</measure>
    <time_frame>6 years</time_frame>
    <description>To be assessed in Microperimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal Structural analysis</measure>
    <time_frame>6 years</time_frame>
    <description>Retinal Structure analysis with Adaptive Optics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fundal Autofluorescence</measure>
    <time_frame>6 years</time_frame>
    <description>Presence or Absence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Visual Fields</measure>
    <time_frame>6 years</time_frame>
    <description>Assessment of Visual Fields with analysis of hill of vision</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Leber Congenital Amaurosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with RPE65-LCA condition
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with RPE65 associated retinal dystrophy

          -  Minimum subject age of 3 years

          -  Able to give consent/parent or guardian able to give consent

        Exclusion Criteria:

          -  Patients unable or unwilling to undertake consent or clinical testing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel Michealides, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCL/Moorfileds</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Morka, MSc</last_name>
    <phone>02037252350</phone>
    <email>anna.morka@athena-vision.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie Bakobaki</last_name>
    <phone>02037252349</phone>
    <email>julie.bakobaki@athena-vision.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kellogg Eye Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>MI 48105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adrienne Chen</last_name>
      <phone>734-232-9167</phone>
      <email>chenad@med.umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Anna Morka</last_name>
      <phone>02037252350</phone>
      <email>anna.morka@athena-vision.com</email>
    </contact_backup>
    <investigator>
      <last_name>John Heckenlively</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Moorfields Eye Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neruban Kumaran, Dr</last_name>
      <email>neruban.kumaran@moorfields.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Sophie Connor</last_name>
      <phone>02075662821</phone>
      <email>sophie.connor@moorfields.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Michel Michealides, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2016</study_first_submitted>
  <study_first_submitted_qc>March 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2016</study_first_posted>
  <last_update_submitted>August 16, 2017</last_update_submitted>
  <last_update_submitted_qc>August 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blindness</mesh_term>
    <mesh_term>Leber Congenital Amaurosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

